Host genetic landscapes shape microbiome acquisition in the animal gut. To identify specific signaling pathways involved, we employed Caenorhabditis elegans and its native microbiome to model these host-microbiome relationships. We tested this by exposing a diverse panel of 38 C. elegans wild strains to the same model microbiome (BIGbiome) to examine natural variation in microbiome acquisition. By day 3 of adulthood the 38 strains could be clustered into three distinct gut microbiome types: Type 1 [8/38; 74%], Ochrobactrum-dominant and low colonization levels; Type 2 [N2 and 4 others], Bacteroidetes-dominant and high colonization levels; and type 3, low colonization levels with microbiomes similar to the lawn. Type 1 strains also exhibit faster growth rates than the others. C. elegans appears to regulate its microbiome by deterministically selecting the microbes that colonize the gut and/or their levels within the gut, which can impact its overall physiology. Using previously generated genomes of these 38 C. elegans strains, we sought to identify the genetic drivers of these gut types. By GWAS, we identified a strong QTL [-log(p-value)= 9.32] in Type 2 strains with genes that are often misregulated in
daf-2/IGFR insulin receptor mutants (35%) and/or respond to xenobiotics (23%). Further, RNAseq analyses of Type 1 strains showed higher insulin ligand and xenobiotic response gene expression than the other types. Expression of many host genes [2344] also strongly correlated with specific gut bacterial abundance-e.g., insulin signaling negatively correlated with Ochrobactrum levels. Tests of genetic mutants in insulin signaling support their roles in modulating host resistance to microbiome colonization, as microbiome colonization is lower in
daf-2 mutant than N2 controls. This is only partially suppressed in
daf-2;
daf-16 animals, suggesting other downstream transcriptional factors contribute to colonization resistance in N2. However,
daf-2(RNAi) of Type 1 strains does not influence overall colonization levels, but does alter Ochrobactrum colonization specifically. Thus, insulin signaling may play a more specific role in shaping the microbiome in wild strains rather than the global colonization resistance observed in these and other N2 studies. Together, our study illustrates how host genetic variation contributes to distinct gut types in C. elegans, and establishes a platform for comprehensive identification of the determinants of host microbiome management.